Lawsuit Contends Drug Requip Resulted in Addiction to Gay Sex, Gambling
A French man, Didier Jambart, 51, is suing GlaxoSmithKline, claiming that a drug they manufactured to help treat Parksinson’s disease instead caused him to engage in gay sex and gambling addiction.
The father of two claims to have attempted suicide on three different occasions after losing the family’s life savings to an Internet gambling addiction.
Lawyers for Jambart also contend their client became a gay sex addict, exposing himself on the Internet and cross-dressing as a woman.
His risky behaviour led him to becoming a victim of rape, Jambart’s attorneys contend. The behaviour stopped once Jambart got off the drug.
They are seeking $618,000 in damages from Glaxo.
A Mayo Clinic study seems to support the claims:
Requip – a dopamine agonist – stimulates the nerves in the brain which are normally stimulated by dopamine – a chemical in the brain which helps control motor functions and movement. Researchers at the renowned Mayo Clinic have suggested that a link exists between dopamine agonist drugs, sexual urges and other intense urges and Requip. Patients who stopped taking the drug or reduced the dosage found that these symptoms were alleviated. Since the Clinic’s study, GlaxoSmithKline added language to the drug’s label which states:
[P]atients should inform their physician if they experience new or increased gambling urges, sexual urges or other intense urges while taking Requip…
Glaxo has yet to comment on the case.
- Jagajeet Chiba, Gambling911.com
